SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-22-001526
Filing Date
2022-12-09
Accepted
2022-12-09 17:07:37
Documents
15
Period of Report
2022-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nhwk_8k.htm   iXBRL 8-K 29321
2 EXHIBIT 10.1 AMENDMENT NO. 1 TO JEFF WOLF EMPLOYMENT AGREEMENT ex10x1.htm EX-10.1 10857
3 EXHIBIT 10.2 AMENDMENT NO. 1 TO WILLIAM OSTRANDER EMPLOYMENT AGREEMENT ex10x2.htm EX-10.2 11048
  Complete submission text file 0001079973-22-001526.txt   273224

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nhwk-20221207.xsd EX-101.SCH 3739
5 XBRL DEFINITION FILE nhwk-20221207_def.xml EX-101.DEF 26569
6 XBRL LABEL FILE nhwk-20221207_lab.xml EX-101.LAB 36527
7 XBRL PRESENTATION FILE nhwk-20221207_pre.xml EX-101.PRE 25193
9 EXTRACTED XBRL INSTANCE DOCUMENT nhwk_8k_htm.xml XML 5277
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 221455545
SIC: 2834 Pharmaceutical Preparations